Background Sleeve gastrectomy with ileal transposition has been shown to be superior to sleeve gastrectomy alone for promoting weight loss in rat and porcine models. The absence of a mouse model for this procedure has impeded efforts to understand the molecular physiology underlying its efficacy. This study demonstrates the long-term survivability of sleeve gastrectomy with ileal transposition in mice. Materials and Methods In this study of technical feasibility, a sleeve gastrectomy with ileal transposition (SGIT), sleeve gastrectomy (SG), or sham surgery (SH) was performed on 7-to 8-week-old C57Bl/6J mice (n = 8 for each). To evaluate long-term survivability, mice were placed on an obesogenic diet and weighed weekly for 10 weeks. The intestinal identity of the transposed segment was assessed with gene expression analysis of duodenal-, jejunal-, and ileal-specific hormones using quantitative polymerase chain reaction. Results Overall, SGIT better prevented weight gain than the SG or sham procedures (10-week post-operative weight: SH 45.3 ± 1.0 g, SG 41.25 ± 1.6 g, SGIT 35.4 ± 0.8 g). Gene expression pattern analysis of three markers of intestinal identity (gastrin, cholecystokinin, and peptide YY) suggests that the ileal identity of the transposed segment is maintained 10 weeks after transposition. Conclusions We demonstrate for the first time a reproducible mouse model of sleeve gastrectomy with ileal transposition. Future studies utilizing this model will expand our understanding of the molecular pathways through which the hindgut regulates satiety.
Introduction
Obesity continues to be one of the world's most significant public health challenges [1] [2] [3] [4] , and metabolic surgery has been increasingly utilized to address this disease and its related co-morbidities [5, 6] . Metabolic surgery has been proven to be safe, reliable, and cost-saving in many instances [7] [8] [9] [10] . The sleeve gastrectomy (SG), which was originally developed as a first stage procedure for patients undergoing a duodenal switch [11, 12] , has been the most commonly performed metabolic surgery in the USA since 2013 [13] . While the SG is associated with fewer long-term complications than the Rouxen-Y gastric bypass (RYGB), it results in less weight loss [14] . Revision operations including SG to RYGB conversions can sometimes improve weight loss outcomes [15, 16] , and as of 2015, revision surgeries accounted for 13.6% of all bariatric procedures [13] . However, revision procedures in general are associated with higher rates of surgical complications [16] [17] [18] [19] , and SG to RYGB conversions in particular may leave patients with RYGB-associated long-term nutritional deficiencies. As the number of metabolic surgeries performed continues to rise, revision-associated complications are also likely to increase [20, 21] . Further complicating this issue, it is unclear why patients may fail their primary SG, a problem stemming from a lack of consensus regarding the mechanistic basis underlying weight loss following metabolic surgery [22] [23] [24] .
The sleeve gastrectomy with ileal transposition (SGIT) is a procedure that may provide insights and solutions. Although the mechanisms underlying weight loss after bariatric surgery remain unclear, a central mediator is believed to be the ileal brake. The ileal brake inhibits upper gut motility to decrease food intake and promote satiety and is a neuroendocrine feedback loop that is activated by the detection of nutrients in the hindgut [25, 26] . In the SGIT, a sleeve gastrectomy is combined with a transposition of a segment of the ileum shortly distal to the duodenum. The SGIT is believed to promote greater weight loss than the SG by shortening the distance that intestinal contents must travel before being detected by the Bhindgut,^thus resulting in earlier satiety [27, 28] . The clinical utilization of this complex procedure as a primary operation has been limited thus far to a few surgeons [29] [30] [31] , but the outcomes reported by these early pioneers are promising and suggest that the procedure can produce weight loss on par with RYGB [29] [30] [31] . Additionally, as the entire length of small bowel is preserved, the procedure is not believed to cause malabsorption-related nutrient deficiencies. However, further molecular characterization of this surgery is necessary to fully understand its physiologic effects and limitations.
Rat models of ileal transposition have been reported since as early as 1984 and have reproducibly demonstrated that the procedure attenuates weight gain when animals are placed on an obesogenic diet post-operatively [32] [33] [34] [35] . More recently, studies in diabetic rat models demonstrated that SGIT could enhance weight loss and improve glycemic control compared to SG alone [27, 28] . SGIT has been shown to be similarly effective in porcine models [28, 29, 36] , but to date, a mouse model has not been published. To analyze the molecular pathways mediating the weight loss effects of SGIT, gene knockout and editing technologies must be employed, and these platforms are best characterized for murine models. A mouse model of SGIT would allow researchers to study the physiological mechanisms through which SGIT enhances the ileal brake. As the average laboratory rat weighs almost ten times as much as a laboratory mouse of comparable age [37, 38] , adapting the procedure to mice is in itself a significant challenge. In this report, we describe for the first time a reliable and reproducible technique for constructing a sleeve gastrectomy with ileal transposition in mice.
Materials and Methods

Animals
All experiments were approved by the Institutional Animal Care and Use Committee of Yale University. Male C57Bl/6J mice (Jackson Labs) were housed in an animal facility with a controlled temperature environment, ad libitum access to food and water, and a 12:12-h light:dark cycle. Ensure® (1.06 kcal/ ml with 14% of energy derived from protein, 22% from fat, and 64% from carbohydrate; Abbott Laboratories) was provided during the immediate pre-and post-operative periods as detailed below.
Pre-and Post-Operative Management
Seven-to eight-week-old mice were given a liquid diet (Ensure®) in addition to their chow for 2 days. For the 2 subsequent days, they were given only Ensure® and water, then fasted 6-8 h before surgery. Post-operatively, mice were placed on a circulating water pad and were monitored every 30 min until they resumed normal activity. Animals were provided with water and Ensure® from post-op day 1-7. From day 8-10, mice were provided with high-fat chow in addition to Ensure®. Starting on day 11, Ensure® was removed and the animals were maintained on high-fat diet (60% fat by kcal, D12492, Research Diets Inc.) and water.
Sleeve Gastrectomy Surgery Technique
Numerous techniques for performing a sleeve gastrectomy in mice have been published [39] [40] [41] [42] [43] [44] [45] , and our technique is based on that described by Hao et al. [44] . Animals were anesthetized with an intraperitoneal injection of a ketamine:xylazine (100:10 mg/ml) at a dose administered per kilogram body weight. A self-retaining retractor was used to expose the abdominal contents. The stomach was exposed, and the thin mesentery was dissected using straight-tipped Vannas microdissecting spring scissors. The stomach contents were washed out through a gastrotomy, and the gastric branches of the splenic artery were identified and cauterized. A custom clamp was applied from the fundus to the pylorus to outline the sleeve, and sutures were placed and the stomach was transected above the clamp. The edges were closed using a continuous suture pattern (7-0 Prolene® Ethicon Inc.), and after releasing the clamp, the suture layer was folded into the stomach and closed with a second continuous layer [44] . The abdominal wall was closed in two layers (7-0 Prolene®). The sleeve surgery required approximately 1 h per mouse.
Sleeve Gastrectomy with Ileal Transposition Surgery Technique
After performing a sleeve gastrectomy as above, a 2-cm segment of ileum located approximately 3-5 cm proximal to the ileocecal valve was isolated (Fig. 1b) . Taking care to preserve the vascular stalks, the segment was tied off at its proximal and distal ends with a pair of interrupted sutures (9-0 Ethilon®, Ethicon Inc). The intestine was divided in between each pair of sutures (Fig. 1c) , and the free segment was temporarily returned to the abdomen. The most proximal and most distal free segments were joined using an end sideto-end side anastomosis as follows.
First, a small volume of sterile saline was injected into each of the two segments to loosen intestinal debris and to gently inflate the intestine. A 4-mm incision was made on both segments using straight-tipped micro-dissecting scissors, and the intestines were arranged end side-to-end side. Stay sutures were placed on the upper and lower corners of the intestine approximately 1 mm from the intestine edge, and tension was applied with mosquito forceps. The tissue edges were apposed with seven interrupted sutures placed approximately 1 mm from the tissue edge (Fig. 1d) . These sutures were tied gently to prevent necrosis at the suture line. When necessary, additional interrupted sutures were placed to close remaining gaps.
After approximating the tissue edge on both sides, a continuous suture was run from the top stay suture to the bottom stay suture. The running suture was locked by bringing the needle through its own loop after reaching the bottom stay suture. This pattern was repeated on the other side until the second stay suture was reached (Fig. 1e ) and the knot was secured with three more throws.
Next, the small intestine was transected approximately 4 cm distal to the ligament of Treitz. The isolated ileal segment, with full neural innervation and intact vascular supply, was inserted in the original peristaltic direction by making two additional end side-to-end side anastomoses. Finally, the abdominal cavity was thoroughly irrigated prior to closure. The SGIT surgeries took approximately 2 h per mouse and a twopart video (Video part 1, Video part 2) demonstrating this procedure can be found in the electronic supplement.
Sham Surgery Technique
As described [46] [47] [48] [49] [50] , sham surgeries were performed by externalizing the bowel and applying pressure with forceps at the SGIT anastomosis sites and along the greater curvature of the stomach. The sham surgery (SH) took approximately 45 min per mouse.
Histology
Samples were prepared for hematoxylin and eosin staining as described [51] . Yale Pathology Tissue Services performed sectioning and staining.
Weight and Blood Glucose Measurement
Animals were weighed weekly and mice were fasted for 10 h prior to measuring blood glucose. Statistical significance was evaluated using an ordinary one-way ANOVA, corrected for multiple comparisons using a Tukey's honestly significant difference (HSD) test with α = 0.05 (Prism 7, GraphPad Software). The slope of each graph of weight vs time was calculated using a linear regression model, and statistical significance between was determined using a one-way ANOVA with Tukey's multiple comparisons test. Values are reported as the mean ± standard error of the mean.
Gene Expression Analysis
Mice were sacrificed 10 weeks post-surgery. Tissue samples were collected from the duodenum, jejunum, and ileum of the sham mice; jejunum of the SG mice; and the transposed ileal segment of the SGIT mice. RNA was isolated from an aliquot of the intestinal tissue of each mouse using the Direct-zol RNA Miniprep kit (Zymo Research). The RNA was reverse transcribed to cDNA using an iScript cDNA synthesis kit (Bio-Rad), and quantitative polymerase chain reaction (qPCR) was performed to measure gene expression. Primer sequences were obtained through OriGene: Gastrin ( M P 2 0 5 2 6 7 ) , P e p t i d e Y Y ( M P 2 1 0 6 8 0 ) , a n d Cholecystokinin (MP202464). Gene expression was analyzed using the comparative CT method (ΔΔCT) with 18S as the endogenous control.
Results
Surgical Outcome
Eight mice were randomized to each of the SG, SGIT, and SH groups. The initial mortality rate was 37.5% (3/8) in the SGIT group. The first SGIT animal to be operated on exhibited lethargy and discomfort on the first postoperative day despite standard pain management protocols, and on autopsy, was found to have a leak at the most proximal anastomosis. The second and third mice appeared to recover well after surgery, but were euthanized after they failed to thrive following initiation of high-fat chow. There was no morbidity and mortality in the subsequent 5 SGIT mice. The SGIT procedure has since been performed in over a dozen mice, with a mortality rate of 0%, as well as with a 0% complication rate after being switched to solid chow. Mortality was 0% (0/8) in the sham and sleeve groups.
Anastomosis Histology
Because the anastomoses were constructed side-to-side, a lumenal cross-section containing the transposed ileal tissue as well as the native jejunal tissue to which it is anastamosed can be obtained (Fig. 1f) . Hematoxylin and eosin staining shows well-healed intestinal walls, with minimal fibrosis at the two suture lines. Comparison of the intestinal villi shows noticeably different villi morphology, without any areas of degeneration or necrosis. The lumina of the anastomoses were patent at 10 weeks, without any evidence of inflammatory changes or stricture.
Weight Loss and Blood Glucose Measurement
Ten weeks after surgery, the sham group weighed 45.3 ± 1.0 g, the sleeve group weighed 41.25 ± 1.6 g, and the SGIT group weighed 35.4 ± 0.8 g (Fig. 2a) . Linear regression analysis was performed on the curves of weight vs time (Sham slope 2.6 ± 0.1, R 2 = 0.98; SG slope 2.3 ± 0.07, R 2 = 0.99; SGIT slope 1.6 ± 0.1, R 2 = 0.93). The slopes of the sham vs SGIT curves and SG vs SGIT curves were significantly different (p < 0.01), but the slopes of the sham vs SG curves were not (p > 0.1). Average weights of the SH were significantly higher than SG or SGIT at weeks 1-10, and SG was significantly higher than SGIT from weeks 4-10. The SGIT group also had the lowest 10-h fasting blood sugar (SGIT 104 ± 6 mg/dl, SG 123 ± 14 mg/dl, Sham 157 ± 11 mg/dl; Fig. 2b) . The difference between the SGIT and sham group was statistically significant (p < 0.05). The sleeve gastrectomy with ileal transposition (SGIT) group gained less weight compared to the sleeve gastrectomy (SG) and sham surgery group. b Ten weeks after surgery, the SGIT group had lower blood glucose compared to the SG and sham surgery groups (SH 157 ± 11 mg/dl, SG 123 ± 14 mg/dl, SGIT 104 ± 6 mg/dl). The difference between the SGIT group and sham surgery group was statistically significant (p < 0.05). c Gene expression for known intestinal hormones was measured in the duodenum, jejunum, and ileum of the sham mice, the jejunum of sleeve gastrectomy mice, and the transposed segment in the SGIT mice. The tissue samples of the jejunum and the transposed segment were taken from the same anatomical location, and thus, the results are normalized to the sham jejunum (expression level ± standard error of mean). The expression of gastrin, a duodenal hormone, was significantly higher in the duodenum than in the jejunum of the sham and SG groups, and the transposed segment in the SGIT group (SH Jejunum 1.0 ± 0.2, SG jejunum 1.1 ± 0.2, SGIT transposed ileum 1.2 ± 0.2, SH duodenum 6.5 ± 3.0. p < 0.05 for SH duodenum vs SH jejunum, SH duodenum vs SG jejunum, and SH duodenum vs SGIT transposed ileum). d Cholecystokinin, a jejunal hormone, is significantly more highly expressed in the jejunum of the sham and SG mice compared to the transposed segment in the SGIT mice (SH jejunum 1.0 ± 0.3, SG jejunum 0.9 ± 0.02, SGIT transposed ileum 0.2 ± 0.02. p < 0.05 for SH jejunum vs SGIT transposed ileum, and SG jejunum vs SGIT transposed ileum). e Peptide YY was higher in the transposed segment of the SGIT mice ileum than in the jejunum of the sham and SG mice indicating the transposed segment maintains an ileal-specific gene expression pattern. There was no significant difference between the transposed segment of the SGIT mice and the native ileum of the SH mice (SH jejunum 1.0 ± 0.2, SG jejunum 0.4 ± 0.04, SGIT transposed ileum 21.9 ± 3.1, SH ileum 19.6 ± 3.0. p < 0.05 for SGIT transposed ileum vs SH jejunum, SGIT transposed ileum vs SG jejunum, SH ileum vs SH jejunum, and SH ileum vs SG jejunum). Asterisks indicate p < 0.05
Gene Expression Analysis of the Transposed Ileal Segment
To determine whether transposition influences the functional identity of the transposed segment, the mRNA expression levels of duodenal-specific, jejunal-specific, and ilealspecific hormones were measured by qPCR. Notably, tissue samples were taken from the same anatomical location: in the SGIT mice, this location corresponded to the transposed ileal segment; in the sham and SG mice, this location corresponded to the jejunum. Tissue from SH duodenum and ileum was also assessed as a positive control for duodenal-and ileal-specific genes. All expression values are presented relative to that of the sham jejunum, which can be considered the Bnative^tis-sue at the transposition site. Gastrin, which is produced primarily in the stomach and the duodenum, was higher in the duodenum than in the jejunum of the sham and SG mice, and in the transposed ileum of the SGIT group (p < 0.05, Fig. 2c ). Cholecystokinin, which is produced in the jejunum, was higher in the jejunal tissue of the sham and SG mice than in the transposed ileum in the SGIT mice (p < 0.05, Fig. 2d ). Peptide YY (PYY) was more highly expressed in the transposed segment of the SGIT mice than in the intestine from the same anatomical position (jejunum) in the sham and SG mice (p < 0.01, Fig. 2e ). There was no significant difference between the expression levels of PYY in the transposed segment of SGIT mice and the ileum of SH mice (p > 0.05, Fig. 2e ).
Discussion
We report for the first time the technical feasibility of a sleeve gastrectomy with ileal transposition in mice. Our technique incorporates previously published surgical techniques for constructing the sleeve gastrectomy and intestinal anastomoses [39] [40] [41] [42] [43] [44] [45] , and shares similarities in the pre-and postoperative management. However, as opposed to previously reported one-layer closures for the anastomoses [39] [40] [41] [42] [43] [44] [45] , we employed a two-layer approach. The first interrupted layer assists in precisely aligning the two walls and revealing potential gaps due to small differences in intestine wall length. The second continuous layer creates a strong, watertight seal. Ten weeks after surgery, the anastomoses appear fully matured, with minimal external adhesion formation. The intestinal lumen remains patent, with minimal fibrosis visible at the anastomosis suture line.
As observed in previous studies of SGIT in rat and porcine models [28, 36] , after surgery, all three groups experienced some weight gain on the high-fat diet. Post-operative weight gain in even the SG and SGIT groups was expected, as all three groups were placed on a highly obesogenic lard-based diet. Similarly, as previously observed in rat and porcine models of SGIT [28, 36] , we confirmed that SGIT can significantly decrease weight gain compared to the sham or sleeve gastrectomy alone. This proof of concept study has thus allowed us to establish a reproducible surgical technique which can be used in future studies to compare SGIT to SG alone in promoting weight loss in obese mice.
The initial mortality rate we observed with this procedure was comparable to the 35.7-44% mortality rate reported for mouse models of RYGB [40, 42, 43] , which is the most similar procedure described in the literature. The first mouse to be operated on in the SGIT group succumbed on the first postoperative day following complications arising from leakage at an anastomosis site. This mortality was likely caused by surgeon inexperience. The two mice that succumbed within a week of resuming high-fat chow diet appeared to have poorly tolerated the rapid diet change. By closely monitoring postoperative food intake, as well as providing liquid Ensure® to mice that take longer to begin eating solid chow, we have reduced the overall mortality rate of this procedure to 0%.
We determined that the ileal identity of the intestinal segment was maintained after transposition. In the sham and SG mice, the tissue in this jejunal region had high expression levels of cholecystokinin, a jejunal hormone, but low levels of gastrin and peptide YY, which are more highly expressed in the duodenum and ileum, respectively. On the other hand, the transposed ileum demonstrated an ileal gene expression pattern with high peptide YY expression, and low gastrin and cholecystokinin expression. Whether the act of transposition modifies the gene expression profile of the transposed ileum compared to the native ileum remains to be determined, but we demonstrate that the transposed segment maintains an ileal pattern of gene expression even in its new jejunal environment at 10 weeks after surgery. This is also supported by clear histological differences in the villi structure of the transposed segment, compared to the jejunal tissue to which it was anastamosed.
By establishing the technical feasibility of this model, we provide investigators with a model which can be used in conjunction with murine models of diet-induced obesity to determine whether and how SGIT promotes greater weight loss compared to SG. We believe this model will allow researchers to better explore the molecular mechanisms underlying the ileal brake, which may provide insights into why some patients fail their primary SG. Activation of ileal brakes, such as peptide YY, by earlier exposure of unabsorbed nutrients to the ileum has been proposed as the mechanism explaining weight loss following SGIT [52, 53] , and at least one clinical experiment has demonstrated direct evidence of this regulatory mechanism [54] . This mechanism is also referred to as the hindgut hypothesis and has recently garnered increased interest due to its potential mechanistic role in other metabolic surgeries [55] [56] [57] . Future studies that utilize this murine model of SGIT may be able to determine the hormones released by the transposed ileum postprandially, as well their contribution to promoting satiety. We hope this model will allow investigators to better dissect the molecular pathways involved in appetite and satiety regulation and uncover novel insights into mechanism of metabolic-surgery-induced weight loss.
Conclusion
The results of the present study have demonstrated for the first time that a mouse model of sleeve gastrectomy with ileal transposition is technically feasible and is better able to prevent weight gain than sleeve gastrectomy. Additionally, through gene expression analysis, we have confirmed that the transposed segment maintains an mRNA expression pattern characteristic of ileal tissue even 10-weeks after transposition into a jejunal environment. Future studies will use nextgeneration sequencing techniques to identify potential molecular pathways involved in mediating satiety regulation. Ultimately, we hope this model will improve obesity treatment by increasing our capability to study the role of distal gut hormones in appetite regulation. 
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